The initial clinical outcomes utilizing [68Ga]Ga-DOTA-MGS5 as an imaging probe revealed that this PET tracer exhibits the capacity to identify local recurrence and metastases in patients with CCK2R-positive tumours [8, 9]. The gene discussed is CCKBR; the disease is neoplasm.